Response of forensic scientific community to Covid-19 pandemic: A Review Article

Abt T, Rosenfeld R, Lopez E. COVID-19 and Homicide: Final Report to Arnold Ventures. http://craftmediabucket.s3.amazonaws.com/uploads/COVID-19-Homicide_061520_Final.pdf. Accessed on 20 Nov. 2020

Mohler G, Bertozzi AL, Carter J, Short MB, Sledge D, Tita GE, Uchida CD, Brantingham PJ. Impact of social distancing during COVID-19 pandemic on crime in Los Angeles and Indianapolis. Journal of Criminal Justice. 2020 May 1;68:101692. https://doi.org/10.1016/j.jcrimjus.2020.101692

Calderon-Anyosa RJ, Kaufman JS. Impact of COVID-19 lockdown policy on homicide, suicide, and motor vehicle deaths in Peru. Preventive medicine. 2021 Feb 1;143:106331. https://doi.org/10.1016/j.ypmed.2020.106331

Payne J, Morgan A. COVID-19 and Violent Crime: A comparison of recorded offence rates and dynamic forecasts (ARIMA) for March 2020 in Queensland, Australia. https://doi.org/10.31235/osf.io/g4kh7

Standish K. A coming wave: suicide and gender after COVID-19. Journal of Gender Studies. 2021 Jan 2;30(1):114-8. https://doi.org/10.1080/09589236.2020.1796608

Sher L. The impact of the COVID-19 pandemic on suicide rates. QJM: An International Journal of Medicine. 2020 Oct;113(10):707-12. https://doi.org/10.1093/qjmed/hcaa202

Joiner TE, Lieberman A, Stanley IH, Reger MA. Might the COVID-19 pandemic spur increased murder-suicide?. Journal of aggression, conflict and peace research. 2020 Jun 25. https://doi.org/10.1108/JACPR-05-2020-0502

Parekh U, Chariot P, Dang C, Stray-Pedersen A, Druid H, Sajantila A. A roadmap to the safe practice of forensic medicine in the COVID-19 pandemic. Journal of forensic and legal medicine. 2020 Oct 15:102036. https://doi.org/10.1016/j.jflm.2020.102036

Sessa F, Bertozzi G, Cipolloni L, Baldari B, Cantatore S, D'Errico S, Di Mizio G, Asmundo A, Castorina S, Salerno M, Pomara C. Clinical-forensic autopsy findings to defeat COVID-19 disease: a literature review. Journal of Clinical Medicine. 2020 Jul;9(7):2026. https://doi.org/10.3390/jcm9072026

Tena EA, Laporta ED. Impact of the COVID-19 pandemic on the Forensic Medical Services in Madrid (Spain). Spanish Journal of Legal Medicine. 2020 Jul 18.

Bañon-Gonzalez R, Carnicero-Caceres S, Suarez-Mier MP, Diaz FJ. Autopsies of suspected SARS-CoV-2 cases. Spanish Journal of Legal Medicine. 2020 Jul 15. https://doi.org/10.1016/j.remle.2020.05.002

Mao D, Zhou N, Zheng D, Yue J, Zhao Q, Luo B, Guan D, Zhou Y, Hu B, Cheng J. Guide to forensic pathology practice for death cases related to coronavirus disease 2019 (COVID-19)(Trial draft). Forensic Sciences Research. 2020 Jan 2;5(1):1-7. https://doi.org/10.1080/20961790.2020.1744400

Parekh U, Kanchan T. COVID-19 instigates resurgence of ‘needless autopsies’ issue in India. Journal of Forensic and Legal Medicine. 2020 Aug 1;74:102028. https://doi.org/10.1016/j.jflm.2020.102028

Duan YJ, Liu Q, Zhao SQ, Huang F, Ren L, Liu L, Zhou YW. COVID-19 and its research progress in forensic toxicology. Fa Yi Xue Za Zhi. 2019;36(2020).

Kanchan T, Saraf A, Krishan K, Misra S. The advantages of virtopsy during the COVID-19 pandemic. Medico-Legal Journal. 2020 Nov;88(1_suppl):55-6. https://doi.org/10.1177/0025817220943035

Dehelean CA, Lazureanu V, Coricovac D, Mioc M, Oancea R, Marcovici I, Pinzaru I, Soica C, Tsatsakis AM, Cretu O. SARS-CoV-2: Repurposed drugs and novel therapeutic approaches—Insights into chemical structure—Biological activity and toxicological screening. Journal of clinical medicine. 2020 Jul;9(7):2084. https://doi.org/10.3390/jcm9072084

WHO Solidarity trial consortium, Hongchao Pan Peto R, Abdool Karim Q, Alejandria M, Henao-Restrepo AM, Hernández García C, Kieny P, Malekzadeh R, Murthy S, Preziosi MP, Reddy S, Periago MR, Sathiyamoorthy V, Røttingen JA, Soumya Swaminathan S. Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results. medRxiv preprint doi: https://doi.org/10.1101/2020.10.15.20209817; this version posted October 15, 2020. Accessed on 23 Nov.2020.

Hsu J. Covid-19: What now for Remdesivir?. bmj. 2020 Nov 20;371. https://doi.org/10.1136/bmj.m4457

Abd-Elsalam S, Esmail ES, Khalaf M, Abdo EF, Medhat MA, Abd El Ghafar MS, Ahmed OA, Soliman S, Serangawy GN, Alboraie M. Hydroxychloroquine in the treatment of COVID-19: a multicenter randomized controlled study. The American Journal of Tropical Medicine and Hygiene. 2020 Oct 7;103(4):1635-9. https://doi.org/10.4269/ajtmh.20-0873

Dominguez-Rodriguez A, Abreu-Gonzalez P, Marik PE, Reiter RJ. Melatonin, cardiovascular disease and COVID-19: A potential therapeutic strategy?. Melatonin Research. 2020 Jun 15;3(3):318-21. https://doi.org/10.32794/mr11250065

Hardeland R, Tan DX. Protection by melatonin in respiratory diseases: valuable information for the treatment of COVID-19. Melatonin Research. 2020 Jun 15;3(3):264-75. https://doi.org/10.32794/mr11250061

Tahamtan A, Tavakoli-Yaraki M, Salimi V. Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients. Expert review of respiratory medicine. 2020 Oct 2;14(10):965-7. https://doi.org/10.1080/17476348.2020.1787836

Zijp TR, Toren-Wielema ML, Panday PV, Kosterink JG, Berger SP, Touw DJ. Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act. Therapeutic drug monitoring. 2020 Aug 1;42(4):652-3. https://doi.org/10.1097/FTD.0000000000000766

Bartiromo M, Borchi B, Botta A, Bagalà A, Lugli G, Tilli M, Cavallo A, Xhaferi B, Cutruzzulà R, Vaglio A, Bresci S. Threatening drug‐drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID‐19). Transplant Infectious Disease. 2020 Aug;22(4):e13286. https://doi.org/10.1111/tid.13286

Meziyerh S, Zwart TC, van Etten RW, Janson JA, van Gelder T, Alwayn IP, de Fijter JW, Reinders ME, Moes DJ, de Vries AP. Severe COVID‐19 in a renal transplant recipient: a focus on pharmacokinetics. American Journal of Transplantation. 2020 Jul;20(7):1896-901. https://doi.org/10.1111/ajt.15943

Leegwater E, Strik A, Wilms EB, Bosma LB, Burger DM, Ottens TH, van Nieuwkoop C. Drug-induced liver injury in a COVID-19 patient: potential interaction of remdesivir with P-glycoprotein inhibitors. Clinical Infectious Diseases. 2020 Jun 28. https://doi.org/10.1093/cid/ciaa883

Russo V, Rago A, Carbone A, Bottino R, Ammendola E, Della Cioppa N, Galante D, Golino P, Nigro G. Atrial fibrillation in COVID-19: from epidemiological association to pharmacological implications. Journal of cardiovascular pharmacology. 2020 Aug 1;76(2):138-45. https://doi.org/10.1097/FJC.0000000000000854

Hodge C, Marra F, Marzolini C, Boyle A, Gibbons S, Siccardi M, Burger D, Back D, Khoo S. Drug interactions: a review of the unseen danger of experimental COVID-19 therapies. Journal of Antimicrobial Chemotherapy. 2020 Dec;75(12):3417-24. https://doi.org/10.1093/jac/dkaa340

Kostoff RN, Briggs MB, Porter AL, Hernández AF, Abdollahi M, Aschner M, Tsatsakis A. The under-reported role of toxic substance exposures in the COVID-19 pandemic. Food and Chemical Toxicology. 2020 Aug 14:111687. https://doi.org/10.1016/j.fct.2020.111687

Race M, Ferraro A, Galdiero E, Guida M, Núñez-Delgado A, Pirozzi F, Siciliano A, Fabbricino M. Current emerging SARS-CoV-2 pandemic: potential direct/indirect negative impacts of virus persistence and related therapeutic drugs on the aquatic compartments. Environmental Research. 2020 Sep 1;188:109808. https://doi.org/10.1016/j.envres.2020.109808

Zaami S, Marinelli E, Varì MR. New trends of substance abuse during COVID-19 pandemic: an international perspective. Frontiers in Psychiatry. 2020 Jul 16;11:700. https://doi.org/10.3389/fpsyt.2020.00700

Farhoudian A, Baldacchino A, Clark N, Gerra G, Ekhtiari H, Dom G, Mokri A, Sadeghi M, Nematollahi P, Demasi M, Schütz CG. COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An international society of addiction medicine practice and policy interest group position paper. Basic and Clinical Neuroscience. 2020 Mar;11(2):133. https://doi.org/10.32598/bcn.11.covid19.1

Dos Santos BP, de Gouveia GC, Eller S, Pego AM, Sebben VC, de Oliveira TF. Is COVID-19 the current world-wide pandemic having effects on the profile of psychoactive substance poisonings?. Forensic toxicology. 2021 Jan;39(1):282-5. https://doi.org/10.1007/s11419-020-00558-3

Rodda LN, West KL, LeSaint KT. Opioid Overdose–Related Emergency Department Visits and Accidental Deaths during the COVID-19 Pandemic. Journal of Urban Health. 2020 Dec;97(6):808-13. https://doi.org/10.1007/s11524-020-00486-y

Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Molecular psychiatry. 2020 Sep 14:1-0. https://doi.org/10.1038/s41380-020-00895-0

Glober N, Mohler G, Huynh P, Arkins T, O’Donnell D, Carter J, Ray B. Impact of COVID-19 pandemic on drug overdoses in Indianapolis. Journal of Urban Health. 2020 Dec;97(6):802-7. https://doi.org/10.1007/s11524-020-00484-0

Slavova S, Rock P, Bush HM, Quesinberry D, Walsh SL. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug and alcohol dependence. 2020 Sep 1;214:108176. https://doi.org/10.1016/j.drugalcdep.2020.108176

Bade R, Simpson BS, Ghetia M, Nguyen L, White JM, Gerber C. Changes in alcohol consumption associated with social distancing and self‐isolation policies triggered by COVID‐19 in South Australia: a wastewater analysis study. Addiction. 2020 Sep 18. https://doi.org/10.1111/add.15256

Wang S, Green HC, Wilder ML, Du Q, Kmush BL, Collins MB, Larsen DA, Zeng T. High-throughput wastewater analysis for substance use assessment in central New York during the COVID-19 pandemic. Environmental Science: Processes & Impacts. 2020;22(11):2147-61. https://doi.org/10.1039/D0EM00377H

Tyndall M. Safer opioid distribution in response to the COVID-19 pandemic. International Journal of Drug Policy. 2020 Sep 1;83:102880. https://doi.org/10.1016/j.drugpo.2020.102880

Wakeman SE, Green TC, Rich J. An overdose surge will compound the COVID-19 pandemic if urgent action is not taken. Nature medicine. 2020 Jun;26(6):819-20. https://doi.org/10.1038/s41591-020-0898-0

Chiappini S, Guirguis A, John A, Corkery JM, Schifano F. COVID-19: the hidden impact on mental health and drug addiction. Frontiers in psychiatry. 2020 Jul 29;11:767. https://doi.org/10.3389/fpsyt.2020.00767

Spagnolo PA, Montemitro C, Leggio L. New challenges in addiction medicine: COVID-19 infection in patients with alcohol and substance use disorders—the perfect storm. American Journal of Psychiatry. 2020 Sep 1;177(9):805-7. https://doi.org/10.1176/appi.ajp.2020.20040417

Vasylyeva TI, Smyrnov P, Strathdee S, Friedman SR. Challenges posed by COVID‐19 to people who inject drugs and lessons from other outbreaks. Journal of the International AIDS Society. 2020 Jul;23(7):e25583. https://doi.org/10.1002/jia2.25583